VAMP7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.013800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.007400E-01
Normal-vs-Stage2
2.302800E-01
Normal-vs-Stage3
1.217000E-01
Normal-vs-Stage4
5.801400E-01
Stage1-vs-Stage2
8.889400E-01
Stage1-vs-Stage3
6.188200E-01
Stage1-vs-Stage4
3.036000E-01
Stage2-vs-Stage3
5.390600E-01
Stage2-vs-Stage4
3.918000E-01
Stage3-vs-Stage4
1.411980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.742610E-01
Normal-vs-AfricanAmerican
6.774400E-01
Normal-vs-Asian
3.117800E-01
Caucasian-vs-AfricanAmerican
2.361000E-01
Caucasian-vs-Asian
9.312800E-01
AfricanAmerican-vs-Asian
4.029400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.496030E-01
Normal-vs-Female
2.948200E-01
Male-vs-Female
1.431620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.541600E-02
Normal-vs-Age(41-60Yrs)
5.481000E-01
Normal-vs-Age(61-80Yrs)
1.277010E-01
Normal-vs-Age(81-100Yrs)
3.028300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.591970E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.794800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.282800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.003700E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.154450E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.999000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.086200E-02
Normal-vs-Daily Drinker
2.866400E-02
Normal-vs-Weekly Drinker
4.122800E-01
Normal-vs-Occasional Drinker
2.208000E-01
Normal-vs-Social Drinker
3.691800E-01
Non Drinker-vs-Daily Drinker
4.152800E-01
Non Drinker-vs-Weekly Drinker
3.086400E-01
Non Drinker-vs-Occasional Drinker
4.217600E-01
Non Drinker-vs-Social Drinker
2.054600E-01
Daily Drinker-vs-Weekly Drinker
1.221790E-01
Daily Drinker-vs-Occasional Drinker
1.409200E-01
Daily Drinker-vs-Social Drinker
6.306100E-02
Weekly Drinker-vs-Occasional Drinker
7.682400E-01
Weekly Drinker-vs-Social Drinker
9.136000E-01
Occasional Drinker-vs-Social Drinker
6.467400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.543400E-01
Normal-vs-Grade 2
9.499400E-01
Normal-vs-Grade 3
9.195400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.874000E-02
Grade 1-vs-Grade 3
2.479800E-01
Grade 1-vs-Grade 4
8.543400E-01
Grade 2-vs-Grade 3
4.378400E-01
Grade 2-vs-Grade 4
9.499400E-01
Grade 3-vs-Grade 4
9.195400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.574400E-02
Normal-vs-NonDiabetic
1.557020E-01
Diabetic-vs-NonDiabetic
4.330200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.269850E-01
Normal-vs-NoPancreatitis
1.505200E-01
Pancreatitis-vs-NoPancreatitis
9.184400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.938620E-01
Normal-vs-N1
2.230600E-01
N0-vs-N1
6.240800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.121800E-01
Normal-vs-TP53-NonMutant
1.791420E-01
TP53-Mutant-vs-TP53-NonMutant
8.552000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
